Thioguanine [clinicaltrials_resource:58fb95df7377c8939e4f4cd4762b68a6]
clinicaltrials:NCT00002590clinicaltrials:NCT00002744clinicaltrials:NCT00002816clinicaltrials:NCT00002944clinicaltrials:NCT00003593clinicaltrials:NCT00003671clinicaltrials:NCT00004056clinicaltrials:NCT00004228clinicaltrials:NCT00005585clinicaltrials:NCT00005596clinicaltrials:NCT00075725Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00103285]clinicaltrials:NCT00109837clinicaltrials:NCT00176462clinicaltrials:NCT00369317Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma [clinicaltrials:NCT00408005]clinicaltrials:NCT00504660clinicaltrials:NCT00549848Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II) [clinicaltrials:NCT00587873]clinicaltrials:NCT00588536Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00613457]Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) [clinicaltrials:NCT00866307]clinicaltrials:NCT00866749clinicaltrials:NCT01190930clinicaltrials:NCT01228331Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [clinicaltrials:NCT01406756]clinicaltrials:NCT01451515Low-Dose Coronary Computed Tomographic Angiography for Early Triage of Acute Chest Pain [clinicaltrials:NCT01770444]Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia [clinicaltrials:NCT02101853]Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma [clinicaltrials:NCT02112916]clinicaltrials:NCT02141100clinicaltrials:NCT02419469
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Thioguanine [clinicaltrials_resource:58fb95df7377c8939e4f4cd4762b68a6]
Bio2RDF identifier
58fb95df7377c8939e4f4cd4762b68a6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:58fb95df7377c8939e4f4cd4762b68a6
identifier
clinicaltrials_resource:58fb95df7377c8939e4f4cd4762b68a6
title
Thioguanine
@en
type
label
Thioguanine [clinicaltrials_resource:58fb95df7377c8939e4f4cd4762b68a6]
@en